Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo

Journal of Virology

Volumn 77, Issue 2, 2003, Pages 1268-1280

  Jones, Jeremy O ^a,b   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE CONTROL; HOST CELL; HUMAN; HUMAN CELL; MICROANALYSIS; MOUSE; NONHUMAN; PREPUCE; PRIORITY JOURNAL; SKIN FIBROBLAST; SKIN GRAFT; T LYMPHOCYTE; TARGET CELL; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; XENOGRAFT;

ANIMALS; CELL LINE; GENE EXPRESSION PROFILING; GUINEA PIGS; HERPESVIRUS 3, HUMAN; HUMANS; MICE; MICE, SCID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 0037225772     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.2.1268-1280.2003     Document Type: Article

References (31)

1. Abendroth, A., B. Slobedman, E. Lee, E. Mellins, M. Wallace, and A. M. Arvin. 2000. Modulation of major histocompatibility class II protein expression by varicella-zoster virus. J. Virol. 74:1900-1907.
2. Abendroth, A., I. Lin, B. Slobedman, H. Ploegh, and A. M. Arvin. 2001. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J. Virol. 75:4878-4888.
3. Altmeyer, A., R. G. Maki, A. M. Feldweg, M. Heike, V. P. Protopopov, S. K. Masur, and P. K. Srivastava. 1996. Tumor-specific cell surface expression of the-KDEL containing, endoplasmic reticular heat shock protein gp96. Int. J. Cancer 69:340-349.
4. Annunziato, P. A., and A. A. Gershon. 2000. Primary immunization against varicella, p. 460-476. In A. Arvin and A. Gershon (ed.), Varicella-Zoster Virus: Virology and Clinical Management. Cambridge University Press, Cambridge, United Kingdom.
5. Argaw, T., J. I. Cohen, M. Klutch, K. Lekstrom, T. Yoshikawa, Y. Asano, and P. R. Krause. 2000. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. J. Infect. Dis. 181: 1153-1157.
6. Arvin, A. 1998. Varicella-zoster virus: virologic and immunologic aspects of persistent infection, p. 183-208. In R. Ahmed and I. Chen (ed.), Persistent Viral Infections. John Wiley & Sons Ltd., New York, N.Y.
7. Arvin, A. M. 2001. Varicella vaccine: Genesis, efficacy, and attenuation. Virology 284:153-158.
8. Arvin, A. M. 2001. Varicella-zoster virus, p. 2731-2768. In D. N. Knipe and P. M. Howley (ed.), Fields Virology, 4th Ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
9. Binder, R. J., D. K. Han, and P. K. Srivastava. 2000. CD91: A receptor for heat shock protein gp96. Nat. Immunol. 1:151-155.
10. Browne, E. P., B. Wing, D. Coleman, and T. Shenk. 2001. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: Viral block to the accumulation of antiviral mRNAs. J. Virol. 75:12319-12330.
11. Chang, Y. E., and L. A. Laimins. 2000. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J. Virol. 74:4174-4182.
12. Cohen, J. I., and S. E. Straus. 2001. Varicella-zoster virus and its replication, p. 2707-2730. In D. N. Knipe and P. M Howtey, M. Howley (ed.), Fields virology, 4th ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
13. Cuadras, M. A., D. A. Feigelstock, S. An, and H. B. Greenberg. 2002. Gene expression pattern in Caco-2 cells following rotavirus infection. J. Virol. 76:4467-4482.
14. Gomi, Y., T. Imagawa, M. Takahashi, and K. Yamanishi. 2000. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J. Med. Virol. 61:497-503.
15. Lim, S. M., S. W. Song, S. L. Kim, Y. J. Jang, K. H. Kim, and H. J. Kim. 2000. Comparison between of the attenuated BR-Oka and the wild type strain of varicella zoster virus (VZV) on the DNA level. Arch. Pharm. Res. 23:418-423.
16. Mallory, S., M. Sommer, and A. M. Arvin. 1997. Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J. Virol. 71:8279-8288.
17. Mayne, M., C. Cheadle, S. S. Soldan, C. Cermelli, Y. Yamano, N. Akhyani, J. E. Nagel, D. D. Taub, K. G. Becker, and S. Jacobson. 2001. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: Induction of proinflammatory mechanisms. J. Virol. 75:11641-11650.
18. + T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:5236-5242.
19. Moffat, J. F., L. Zerboni, P. R. Kinchington, C. Grose, H. Kaneshima, and A. M. Arvin. 1998. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72:965-974.
20. Mossman, K. L., P. F. Macgregor, J. J. Rozmus, A. B. Goryachev, A. M. Edwards, and J. R. Smiley. 2001. Herpes simplex virus triggers and then disarms a host antiviral response. J. Virol. 75:750-758.
21. Nieland, T. J., M. C. Tan, M. Monne-van Muijen, F. Koning, A. M. Kruisbeek, and G. M. van Bleek. 1996. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc. Natl. Acad. Sci. USA 93:6135-6139.
22. Ruyechan, W. T., and J. Hay (ed.). 2000. VZV Replication in Varicella Zoster Virus: Virology and Clinical Management. Cambridge University Press, Cambridge, United Kingdom.
23. Schena, M., D. Shalon, R. W. Davis, and P. O. Brown. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470.
24. Sherlock, G., T. Hernandez-Boussard, A. Kasarskis, G. Binkley, J. C. Matese, S. S. Dwight, M. Kaloper, S. Weng, H. Jin, C. A. Ball, M. B. Eisen, P. T. Spellman, P. O. Brown, D. Botstein, and J. M. Cherry. 2001. The Stanford Microarray Database. Nucleic Acids Res. 29:152-155.
25. Sommer, M. H., E. Zagha, O. K. Serrano, C. C. Ku, L. Zerboni, A. Baiker, R. Santos, M. Spengler, J. Lynch, C. Grose, W. Ruyechan, J. Hay, and A. M. Arvin. 2001. Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J. Virol. 75:8224-8239.
26. Takahashi, M., T. Otsuka, Y. Okuno, Y. Asano, and T. Yazaki. 1974. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet ii:1288-1290.
27. Thomas, J. T., S. T. Oh, S. S. Terhune, and L. A. Laimins. 2001. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J. Virol. 75:7564-7571.
28. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98:5116-5121.
29. White, C. J. 1997. Varlcella-zoster virus vaccine. Clin. Infect. Dis. 24:753-763.
30. Zerboni, L., M. Sommer, C. F. Ware, and A. M. Arvin. 2000. Varicella-zoster virus infection of a human CD4-positive T-cell line. Virology 270:278-285.
31. Zheng, H., J. Dai, D. Stoilova, and Z. Li. 2001. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J. Immunol. 167:6731-6735.